menu
    • menu

    Company profile for AN2 Therapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to develop therapeutics to treat rare, chronic, and serious infectious diseases in areas of high unmet medical need. As leaders in the field of antimicrobials, we also have both an obligation and a strong desire to combine our drug discovery and development expertise with resources available from public and private organizations to address high unmet needs in global health.AN2 Therapeutics, Inc. is a biopharmace...
    Our mission is to develop therapeutics to treat rare, chronic, and serious infectious diseases in areas of high unmet medical need. As leaders in the field of antimicrobials, we also have both an obligation and a strong desire to combine our drug discovery and development expertise with resources available from public and private organizations to address high unmet needs in global health.AN2 Therapeutics, Inc. is a biopharmaceutical company dedicated to developing therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AN2 TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1800 El Camino Real, Suite D Menlo Park, CA 94027
    Telephone
    Telephone
    650-331-9090
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.an2therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/an2-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AN2 Therapeutics To Launch 90-Patient Trial For Epetraborole
    AN2 Therapeutics To Launch 90-Patient Trial For Epetraborole

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112479198/en/AN2-Therapeutics-Announces-FDA-Clearance-to-Proceed-with-90-Patient-Investigator-Initiated-Trial-IIT-of-Epetraborole-in-Patients-with-M.-abscessus-Lung-Disease

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    AN2 Therapeutics Reveals Q3 2025 Financials & Key Updates
    AN2 Therapeutics Reveals Q3 2025 Financials & Key Updates

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112188096/en/AN2-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-and-Scientific-Highlights

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB
    GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110907693/en/AN2-Therapeutics-Announces-Research-Collaboration-With-GSK-to-Advance-Boron-Based-LeuRS-Inhibitors-Targeting-Tuberculosis-TB

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    AN2 Therapeutics Joins Fireside Chat At Evercore HealthCONx
    AN2 Therapeutics Joins Fireside Chat At Evercore HealthCONx

    06 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251106433022/en/AN2-Therapeutics-to-Participate-in-Fireside-Chat-at-Evercore-HealthCONx-Conference

    BUSINESS WIRE
    06 Nov 2025
    Share Share
    AN2 Begins Human Trial of Oral AN2-502998 for Chagas Disease
    AN2 Begins Human Trial of Oral AN2-502998 for Chagas Disease

    12 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250812650698/en/AN2-Therapeutics-Commences-First-in-Human-Clinical-Trial-of-Oral-AN2-502998-for-Chagas-Disease

    BUSINESSWIRE
    12 Aug 2025
    Share Share
    AN2 Therapeutics Announces Q2 2025 Financial Results and Updates
    AN2 Therapeutics Announces Q2 2025 Financial Results and Updates

    12 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250812515889/en/AN2-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Business-and-Scientific-Highlights

    BUSINESSWIRE
    12 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search